Is there any relation between CDKN2 p16 and MDM2 variants and the development of primary brain tumors?

被引:0
|
作者
Kafadar, A. [1 ]
Kucukhuseyin, O. [2 ]
Cacina, C. [2 ]
Yenilmez, E. N. [2 ]
Turan, S. [2 ]
Kafadar, D. [3 ]
Ozkok, E. [4 ]
Yaylim, I. [2 ]
机构
[1] Istanbul Univ, Cerrahpasa Fac Med, Neurosurg, Istanbul, Turkey
[2] Istanbul Univ, Inst Expt Med, Mol Med, Istanbul, Turkey
[3] Bagcilar Training & Res Hosp, Family Med, Istanbul, Turkey
[4] Istanbul Univ, Inst Expt Med, Neurosci, Istanbul, Turkey
关键词
Brain tumors; MDM2; p16;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
SUN-034
引用
收藏
页码:76 / 76
页数:1
相关论文
共 50 条
  • [1] FREQUENCY OF HOMOZYGOUS DELETION AT P16/CDKN2 IN PRIMARY HUMAN TUMORS
    CAIRNS, P
    POLASCIK, TJ
    EBY, Y
    TOKINO, K
    CALIFANO, J
    MERLO, A
    MAO, L
    HERATH, J
    JENKINS, R
    WESTRA, W
    RUTTER, JL
    BUCKLER, A
    GABRIELSON, E
    TOCKMAN, M
    CHO, KR
    HEDRICK, L
    BOVA, GS
    ISAACS, W
    KOCH, W
    SCHWAB, D
    SIDRANSKY, D
    [J]. NATURE GENETICS, 1995, 11 (02) : 210 - 212
  • [2] Do CDKN2 p16 540 C>G, CDKN2 p16 580 C>T, and MDM2 SNP309 T>G Gene Variants Act on Colorectal Cancer Development or Progression?
    Tuna, Gulay
    Kucukhuseyin, Ozlem
    Arikan, Soykan
    Saglam, Esra Kaytan
    Guler, Erkan
    Cacina, Canan
    Oztop, Ozge
    Turan, Saime
    Korkmaz, Gurbet
    Yaylim, Ilhan
    [J]. DNA AND CELL BIOLOGY, 2013, 32 (07) : 400 - 408
  • [3] CDKN2/p16 inactivation and p16 immunohistochemistry in astrocytic gliomas
    Piva, R
    Cavalla, P
    Bortolotto, S
    Cordera, S
    Grosso, R
    Richiardi, P
    Dutto, A
    Schiffer, D
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 1998, 12 (01) : 55 - 58
  • [4] Expression of MDM2 and p16 in Angiomyolipoma
    Lin, Xiaoqi
    Laskin, William B.
    [J]. MODERN PATHOLOGY, 2017, 30 : 19A - 19A
  • [5] Expression of MDM2 and p16 in Angiomyolipoma
    Lin, Xiaoqi
    Laskin, William B.
    [J]. LABORATORY INVESTIGATION, 2017, 97 : 19A - 19A
  • [6] Expression of MDM2 and p16 in angiomyolipoma
    Lin, Xiaoqi
    Laskin, William B.
    Lu, Xinyan
    Zhang, Yaxia
    [J]. HUMAN PATHOLOGY, 2018, 75 : 34 - 40
  • [7] CDKN2(p16)基因研究进展
    何正文
    曹亚
    [J]. 癌症, 1998, (01) : 75 - 77
  • [8] Inactivation of the p16/CDKN2 gene in carcinomas of the hypopharynx
    Liengswangwong, U
    Konishi, N
    Hiasa, Y
    Naito, H
    Yane, K
    [J]. CANCER LETTERS, 1999, 143 : S33 - S33
  • [9] CDKN2(P16)基因的研究现状
    曹文静
    [J]. 实用肿瘤学杂志, 1999, (04) : 312 - 314
  • [10] Lack of p16/CDKN2 alterations in thyroid carcinomas
    Yane, K
    Konishi, N
    Kitahori, Y
    Naito, H
    Okaichi, K
    Ohnishi, T
    Miyahara, H
    Matsunaga, T
    Hiasa, Y
    [J]. CANCER LETTERS, 1996, 101 (01) : 85 - 92